Detail Information of Post-Translational Modifications
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0377 Transporter Info | ||||
Gene Name | SLC49A2 | ||||
Transporter Name | Feline leukemia virus subgroup C receptor-related protein 2 | ||||
Gene ID | |||||
UniProt ID | |||||
Post-Translational Modification of This DT | |||||
Overview of SLC49A2 Modification Sites with Functional and Structural Information | |||||
Sequence |
MVNEGPNQEE SDDTPVPESA LQADPSVSVH PSVSVHPSVS INPSVSVHPS SSAHPSALAQ
PSGLAHPSSS GPEDLSVIKV SRRRWAVVLV FSCYSMCNSF QWIQYGSINN IFMHFYGVSA FAIDWLSMCY MLTYIPLLLP VAWLLEKFGL RTIALTGSAL NCLGAWVKLG SLKPHLFPVT VVGQLICSVA QVFILGMPSR IASVWFGANE VSTACSVAVF GNQLGIAIGF LVPPVLVPNI EDRDELAYHI SIMFYIIGGV ATLLLILVII VFKEKPKYPP SRAQSLSYAL TSPDASYLGS IARLFKNLNF VLLVITYGLN AGAFYALSTL LNRMVIWHYP GEEVNAGRIG LTIVIAGMLG AVISGIWLDR SKTYKETTLV VYIMTLVGMV VYTFTLNLGH LWVVFITAGT MGFFMTGYLP LGFEFAVELT YPESEGISSG LLNISAQVFG IIFTISQGQI IDNYGTKPGN IFLCVFLTLG AALTAFIKAD LRRQKANKET LENKLQEEEE ESNTSKVPTA VSEDHL |
||||
PTM type |
X-Phosphorylation
X-Ubiquitination
X: Amino Acid
|
Phosphorylation |
|||||
---|---|---|---|---|---|
Serine |
3 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
PTM Phenomenon 1 |
Have the potential to influence SLC49A2 | [1] , [2] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Serine |
Modified Location |
512 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC49A2 Serine 512 has the potential to affect its expression or activity. | ||||
PTM Phenomenon 2 |
Have the potential to influence SLC49A2 | [1] , [2] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Serine |
Modified Location |
515 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC49A2 Serine 515 has the potential to affect its expression or activity. | ||||
PTM Phenomenon 3 |
Have the potential to influence SLC49A2 | [3] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Serine |
Modified Location |
522 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC49A2 Serine 522 has the potential to affect its expression or activity. | ||||
Threonine |
1 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
PTM Phenomenon 1 |
Have the potential to influence SLC49A2 | [1] , [2] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Threonine |
Modified Location |
514 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC49A2 Threonine 514 has the potential to affect its expression or activity. | ||||
Ubiquitination |
|||||
Glycine |
1 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
PTM Phenomenon 1 |
Have the potential to influence SLC49A2 | [4] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Glycine |
Modified Location |
299 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Ubiquitination at SLC49A2 Glycine 299 has the potential to affect its expression or activity. | ||||
Lysine |
2 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
PTM Phenomenon 1 |
Have the potential to influence SLC49A2 | [4] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Lysine |
Modified Location |
504 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Ubiquitination at SLC49A2 Lysine 504 has the potential to affect its expression or activity. | ||||
PTM Phenomenon 2 |
Have the potential to influence SLC49A2 | [5] , [6] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Lysine |
Modified Location |
516 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Ubiquitination at SLC49A2 Lysine 516 has the potential to affect its expression or activity. | ||||
Valine |
1 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
PTM Phenomenon 1 |
Have the potential to influence SLC49A2 | [5] , [6] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Valine |
Modified Location |
311 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Ubiquitination at SLC49A2 Valine 311 has the potential to affect its expression or activity. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.